1-[2-{N-Ethyl-N-(4-(4-methylpiperazinyl)methylbenzyl)amino}ethyl]-3-(1-naphthylmethyl)-2-imidazolidinylidenepropanedinitrile | 471929-54-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-[2-{N-Ethyl-N-(4-(4-methylpiperazinyl)methylbenzyl)amino}ethyl]-3-(1-naphthylmethyl)-2-imidazolidinylidenepropanedinitrile
• 英文别名: 2-[1-[2-[Ethyl-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]amino]ethyl]-3-(naphthalen-1-ylmethyl)imidazolidin-2-ylidene]propanedinitrile
• CAS: 471929-54-1
• 化学式: C₃₄H₄₁N₇
• 分子量: 547.746
• InChiKey: KQAVMXLMSWMGNE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  41
• 可旋转键数：
  10
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  63.8
• 氢给体数：
  0
• 氢受体数：
  7

文献信息

• US6469002B1
  申请人：——

  公开号：US6469002B1

  公开（公告）日：2002-10-22
• [EN] IMIDAZOLIDINE COMPOUNDS AND THEIR USE AS CXCR3 ANTAGONISTS<br/>[FR] COMPOSES D'IMIDAZOLIDINE ET LEUR UTILISATION COMME ANTAGONISTES DE CXCR3
  申请人：MILLENNIUM PHARM INC

  公开号：WO2002085861A1

  公开（公告）日：2002-10-31

  Disclosed are novel compounds and a method of treating inflammatory diseases. The method comprises administering to an individual in need an effective amount of an imidazolidine compound represented by Structural Formula (1): and physiologically of pharmaceutically acceptable salts thereof.